Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
作者信息
Lichtenstein Gary R
机构信息
Department of Medicine, Hospital of the University of Pennsylvania, School of Medicine, PA, USA.
出版信息
Am J Gastroenterol. 2005 Jul;100(7):1433-5. doi: 10.1111/j.1572-0241.2005.50622_1.x.
Abstract
摘要
Zotero 插件